Colesevelam
کولسولام
❤️ Cardiovascular SystemBile acid sequestrant
Market / country: 🇺🇸 USA
Welchol (US)
🧮 Dose calculator
Hyperlipidemia / heterozygous familial hypercholesterolemia · Regimen source: FDA Welchol · 2.2
- • Or one 3.75 g packet daily. Check triglycerides first; separate other drugs per label. FDA Welchol · 2.2FDA Welchol · 2.1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Triglycerides >500 mg/dL; history of hypertriglyceridaemia-induced pancreatitis; history of bowel obstruction. FDA Welchol · 4
Warnings
- • Raised triglycerides and pancreatitis; GI obstruction; fat-soluble vitamin deficiency; drug absorption interactions; PKU (suspension). FDA Welchol · 5
Formulations
- 625 mg tablet — tablet 🇺🇸 USA FDA Welchol · 3
- 3.75 g packet for oral suspension — sachet 🇺🇸 USA FDA Welchol · 3
👥 Special populations
- 🤰 PregnancyNo specific problem stated
Label: minimal systemic absorption; fetal exposure not expected. FDA Welchol · 8.1
“Risk Summary WELCHOL is not absorbed systemically following oral administration, and maternal use is not expected to result in fetal exposure to the drug.”
- 🤱 BreastfeedingNo specific problem stated
Label: infant exposure not expected. FDA Welchol · 8.2
“Risk Summary WELCHOL is not absorbed systemically by the mother following oral administration, and breastfeeding is not expected to result in exposure of the child to WELCHOL.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Welchol · 8.4
“Primary Hyperlipidemia The safety and effectiveness of WELCHOL to reduce LDL-C levels in boys and postmenarchal girls 10 to 17 years of age with HeFH who are unable to reach LDL-C target levels despite an adequate trial of dietary therapy and lifestyle modification have been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Welchol · 8.5
“Primary Hyperlipidemia Of the 1350 patients enrolled in the hyperlipidemia clinical studies, 349 (26%) were ≥65 years old, and 58 (4%) were ≥75 years old.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Welchol · 8.3
“Contraception Use of WELCHOL may reduce the efficacy of oral contraceptives.”
🔗 Reference links
- FDA (approval record)NDA021176
- DailyMed (FDA label)FDA Welchol
- MedlinePlus (NIH)Colesevelam
- WHO ATC/DDDC10AC04
- Darooyab (Iran)Colesevelam
🇮🇷 Not found in Iran list Darooyab · G-1608/Colesevelam
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Welchol · 3FDA Welchol · 2.2FDA Welchol · 2.1FDA Welchol · 4FDA Welchol · 5FDA Welchol · 8.1FDA Welchol · 8.2FDA Welchol · 8.4FDA Welchol · 8.5FDA Welchol · 8.3FDA Welchol · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1608/Colesevelam
- Clinical review⚠ Unverified